Pelvic Congestion Syndrome Post Tubal Ligation Versus Salpingectomy Performed During Caesarean Section
Pelvic Congestion Syndrome Following Salpingectomy Compared to Tubal Ligation at Time of Caesarean Section
1 other identifier
interventional
64
1 country
1
Brief Summary
Permanent tubal sterilization during Caesarean section is a reliable method of contraception. It is done either by bilateral tubal ligation or bilateral salpingectomy according to surgeon's preference. Studies revealing bilateral salpingectomy has an added benefit of primary prevention of ovarian cancer has encouraged surgeons to perform bilateral salpingectomy rather than tubal ligation as a risk reducing surgery owing to the acceptance of fallopian tubes as the origin of high grade serous ovarian cancer. Another aspect to take into consideration is the post tubal ligation syndrome as it severely affects the quality of life. Diagnosis is based on clinical picture, imaging, and exclusion of other causes of chronic pelvic pain. Women experience dysmenorrhea, dyspareunia, menstrual irregularities, and pelvic pain. The gold standard is venography; however, the first choice for initial evaluation is duplex ultrasound. In this study, we assess impact of bilateral salpingectomy versus tubal ligation in terms of pelvic congestion by participant's symptoms and ultrasound findings
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2024
CompletedStudy Start
First participant enrolled
May 21, 2024
CompletedFirst Posted
Study publicly available on registry
July 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedJuly 19, 2024
April 1, 2024
3 months
April 23, 2024
July 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
symptoms of pelvic congestion syndrome
A questionnaire to detect changes in menstrual pattern or new onset of pelvic pain.
Ten weeks postoperative
Secondary Outcomes (2)
signs of pelvic congestion syndrome
Ten weeks postoperative
intraoperative complications
intraoperative
Study Arms (2)
Participants undergoing caesarean section and salpingectomy.
ACTIVE COMPARATORParticipants undergoing caesarean section and tubal ligation
ACTIVE COMPARATORInterventions
Salpingectomy will be done by clamping, division and ligation using adsorbable suture material (2-0 Vicryl) and excising the tube till it's isthmic part by scissors.
Tubal ligation will be done by Parkland technique. An opening is made in an avascular section of the mesosalpinx by electrocautery. Two absorbable suture ties (2-0 Vicryl) are passed through the opening and used to ligate the proximal and distal ends of the segment (at least 2 cm) which will get excised by scissors.
Eligibility Criteria
You may qualify if:
- Females undergoing caesarean section and requesting tubal sterilization as a permanent method of contraception.
- years or older
You may not qualify if:
- Previous history of tubal surgery (changes in blood flow)
- Previous history of oophorectomy (changes in blood flow)
- Congenital anomalies or malformations in fallopian tubes or ovaries. (affection of normal anatomy of pelvic blood vessels)
- Women diagnosed with pelvic congestion. (Known cause for pelvic congestion other than tubal sterilization)
- High likelihood of lost to follow up.
- Inability to provide good data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams Maternity Hospitals
Cairo, Abaseya, 11588, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2024
First Posted
July 19, 2024
Study Start
May 21, 2024
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
July 19, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
A case report form for each participant will be shared.